Hardeep Singh

Hardeep Singh is a seasoned professional in the pharmaceutical and healthcare industry with extensive experience in strategic roles and account management. Currently serving as the Portfolio Strategy Lead for ANZ at Recordati Rare Diseases since August 2022, Hardeep also holds the title of ANZ Franchise Manager for Oncology. Prior to this, Hardeep was the ANZ Business Lead at EUSA Pharma, and a Haematology/Oncology ANZ Key Account Manager from May 2019 to August 2022. Hardeep's career also includes positions at GSK as a Urology Hybrid Sales Representative and Medical Sales Representative, and at Hospira as a Services Coordinator. Hardeep Singh is an alumnus of Monash University.